It could be an issue with having/raising the money, it could be an issue with not wanting to pay the money (due to other options), or it could be an issue with negotiation of deal details.
Any way you look at it, it's certainly not a positive development.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links